Key result
Incomplete revascularization plus optimal medical therapy was not superior to medical therapy alone for 1-year death (16% vs 12%; p=1.000) or ACS (16% vs 32%; p=0.321) in patients ineligible for CABG.
Why the study?
Does incomplete revascularization plus optimal medical therapy improve 1-year clinical outcomes compared to optimal medical therapy alone in patients with multivessel coronary artery disease not eligible for CABG?
RCT (n=50)
1:1
Does incomplete revascularization plus optimal medical therapy improve 1-year clinical outcomes compared to optimal medical therapy alone in patients with multivessel coronary artery disease not eligible for CABG?
Incomplete revascularization added to optimal medical therapy improves angina symptoms but does not significantly improve 1-year hard clinical outcomes in patients with multivessel CAD ineligible for CABG.
Does not support incomplete revascularization for hard outcomes in CABG-ineligible patients; confirms medical therapy sufficiency and leaves symptom-focused questions open.
The purpose of this study was to compare the impact of incomplete revascularization (IR) plus optimal medical therapy (OMT) to OMT alone on 1 year clinical outcomes in patients with multivessel coronary artery disease (MVD) who were not eligible for coronary bypass graft surgery (CABG). This is a prospective randomized study conducted on 50 selected patients with chronic stable angina with documented MVD and CABG was refused by the surgeon due to poor distal vessel quality. Patients were randomized 1:1 into two groups, group (I): 25 patients were subjected to OMT alone and group (II): 25 patients were subjected to IR plus OMT. All patients were subjected to 1 year follow up. The baseline patients’ details were matched. At 1 year; death occurred slightly more in group II (16% versus 12%; p = 1.000), ACS occurred more in the group I (32% versus 16%; p = 0.321) while freedom from angina occurred more in group II (20% versus 4%; p = 0.189). The OMT alone did not affect neither the level of angina class nor EF; while the IR plus OMT markedly improved the decline in the level of angina class (p = 0.011), but it did not improve EF significantly (p = 0.326). In patients with MVD who were not eligible for CABG; IR plus OMT was not superior to OMT alone in improving the 1year clinical outcomes except the improvement in the level of angina class, which could be the adopted strategy to improve the quality of life in such patients but with close follow up.
No takes yet. Share an insight, caveat, or question.
Sadaka et al. (2012) conducted an RCT in multivessel coronary artery disease (MVD) not eligible for CABG (n=50). Incomplete revascularization plus optimal medical therapy vs. Optimal medical therapy alone was evaluated on death (p=1.000). Incomplete revascularization plus optimal medical therapy was not superior to medical therapy alone for 1-year death (16% vs 12%; p=1.000) or ACS (16% vs 32%; p=0.321) in patients ineligible for CABG.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: